Researcher
Ghesquiere Bart
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology, (Bio)molecular modelling and design, Analytical biochemistry, Auto-ecology, Biogeography and phylogeography, Anthropological genetics, Bacteriology, Cell death and senescence, Epigenomics, Environmental safety and health of nanotechnology, Medical biophysics, General diagnostics, Adaptive immunology, Behavioural neuroscience
- Disciplines (KU Leuven):Metabolomics, Separation techniques, Spectrometry, Regulation of metabolism
- See also: Bart Ghesquière (KU Leuven)
Affiliations
- Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Responsible
From1 Oct 2016 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Sep 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Sep 2017 → Today - Ghesquière Lab (Research group)
Responsible
From1 Sep 2017 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Jan 2017 → Today - Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Member
From1 Oct 2016 → 30 Sep 2022 - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 30 Sep 2014
Projects
1 - 5 of 5
- Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories.From1 May 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Ghesquière Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- BE19-COMMUNITYLED (Bestaat uit de projecten GALAXY en PLANTS en gedeelte voor BaGh)From1 Jun 2019 → 31 May 2021Funding: EMBL
- VIB Grant for Ghesquière Lab_Period:2018-01-01-2021-12-31From1 Jan 2018 → 31 Dec 2021Funding: FRI - Project driven research
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
Publications
31 - 40 of 75
- Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation.(2021)
Authors: Federico Virga, Federica Cappellesso, Benoît Stijlemans, Rosa Trotta, Jolien Vandewalle, Carla Riera Domingo, Damya Laoui, Bart Ghesquière, Claude Libert, Jo Van Ginderachter, et al.
Pages: eabf0466 - Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells.(2021)
Authors: Bart Ghesquière
Pages: eabe8349 - Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate.(2021)
Authors: Bart Ghesquière
Pages: 252 - A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS(2021)
Authors: Bart Ghesquière, Wesley Vermaelen
Pages: 38 - Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications.(2021)
Authors: Silvia Radenkovic, Bart Ghesquière
Pages: 887-900 - Hypoxia drives murine neutrophil protein scavenging to maintain central carbon metabolism.(2021)
Authors: Bart Ghesquière, Wesley Vermaelen
Pages: e134073 - Cardiac Microvascular Endothelial Cells in Pressure Overload-Induced Heart Disease.(2021)
Authors: Pauline de Zeeuw, Pieter Baatsen, Bart Ghesquière, Peter Carmeliet
Pages: e006979 - Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype.(2021)
Authors: Mathias Declercq, Pauline de Zeeuw, Nadine Conchinha, Vincent Geldhof, Melissa Garcia Caballero, Stefan Vinckier, Bart Ghesquière, Mieke Dewerchin, Peter Carmeliet, Lucas Treps, et al.
Pages: 2000261 - Exercise-induced angiogenesis is dependent on metabolically primed ATF3/4(2021)
Authors: Bart Ghesquière
Pages: 1793-1807.e9 - Neutrophils Fuel Effective Immune Responses through Gluconeogenesis and Glycogenesis.(2021)
Authors: Massimiliano Mazzone, Bart Ghesquière, Peter Carmeliet
Pages: 411-423.e4
Patents
1 - 5 of 5
- METHODS FOR ANALYZING THE PERFUSATE OF AN EX SITU MACHINE PERFUSED KIDNEY (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)